CompletedPhase 4NCT00402610

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Studying Primary genito-urinary tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sociedad Andaluza de Enfermedades Infecciosas
Principal Investigator
Antonio Rivero, MD PhD
Hospital Universitario Reina Sofía, Córdoba, Spain
Intervention
isoniazid, rifampin + isoniazid, rifampin + pyrazinamide or not treatment(drug)
Enrollment
332 enrolled
Eligibility
18-65 years · All sexes
Timeline
1994 – 1998

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00402610 on ClinicalTrials.gov

Other trials for Primary genito-urinary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary genito-urinary tuberculosis →

← Back to all trials